EUVIMEDEUVIMED entdecken
Crossref

Research Progress of PCSK9 and Its Inhibitors in the Treatment of Hepatocellular Carcinoma

亚峰 刘

Pharmacy Information · 2026 · 15 (02) · 112-122

DOI: 10.12677/pi.2026.152014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacy Information, 2026. Verfasst von 亚峰 刘. Die Arbeit nennt 51 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

刘, 亚. (2026). Research Progress of PCSK9 and Its Inhibitors in the Treatment of Hepatocellular Carcinoma. Pharmacy Information, 15(02), 112-122. https://doi.org/10.12677/pi.2026.152014

Vancouver

刘 亚. Research Progress of PCSK9 and Its Inhibitors in the Treatment of Hepatocellular Carcinoma. Pharmacy Information. 2026;15(02):112-122. doi:10.12677/pi.2026.152014

BibTeX
@article{2026,
  author = {刘, 亚峰},
  title = {Research Progress of PCSK9 and Its Inhibitors in the Treatment of Hepatocellular Carcinoma},
  journal = {Pharmacy Information},
  year = {2026},
  volume = {15},
  number = {02},
  pages = {112--122},
  doi = {10.12677/pi.2026.152014}
}
Kostenlos starten →